DEPUY PINNACLE COMPLETE ACETABULAR HIP SYSTEM

FDA Premarket Approval P090002 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the addition of the trilock bps (bone preserving hip stem) to the list of compatible femoral stem components. The device, as modified, will be marketed under the trade name depuy pinnacle complete acetabular hip system and is indicated as a single use device intended for uncemented fixation. The device is intended as a primary joint replacement prosthesis in total hip arthroplasty for skeletally mature patients suffering at least moderate pain in the hip joint from non-inflammatory degenerative joint disease (nidjd) and its composite diagnoses of osteoarthritis (oa) or post-traumatic arthritis. The device¿s inserts (pinnacle ultamet) are only intended for use with depuy¿s femoral and acetabular components having matching outer and inner diameters.

DeviceDEPUY PINNACLE COMPLETE ACETABULAR HIP SYSTEM
Generic NameProsthesis, Hip, Semi-constrained, Ceramic-on-metal Articulation
ApplicantDEPUY ORTHOPAEDICS, INC.
Date Received2012-01-19
Decision Date2012-04-17
PMAP090002
SupplementS002
Product CodeOVO 
Advisory CommitteeOrthopedic
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address DEPUY ORTHOPAEDICS, INC. p.o Box 988 700 Orthopaedic Drive warsaw, IN 46581-0988

Supplemental Filings

Supplement NumberDateSupplement Type
P090002Original Filing
S009 2013-03-12 135 Review Track For 30-day Notice
S008
S007 2012-11-28 Special (immediate Track)
S006 2012-10-25 30-day Notice
S005 2012-08-03 Special (immediate Track)
S004 2012-05-18 30-day Notice
S003 2012-03-27 30-day Notice
S002 2012-01-19 Real-time Process
S001 2011-09-07 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.